SCHEMBL12501005

SCHEMBL12501005

Cc1cc2c(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)ccnc2cc1OCC1CCN(C)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 14/20 0.62
KDR P35968 6/20 0.62
FGFR1 P11362 5/20 0.62
FLT1 P17948 4/20 0.62
FLT4 P35916 4/20 0.62
RET P07949 4/20 0.62
FGFR2 P21802 3/20 0.62
FGFR3 P22607 3/20 0.62
PDGFRB P09619 3/20 0.62
KIT P10721 3/20 0.62
PDGFRA P16234 3/20 0.62
RIPK2 O43353 2/20 0.62
STK10 O94804 2/20 0.62
ABL1 P00519 2/20 0.62
BCR P11274 2/20 0.62
SLC6A3 Q01959 2/20 0.62
DDR1 Q08345 2/20 0.62
MAP4K2 Q12851 2/20 0.62
PTK6 Q13882 2/20 0.62
DDR2 Q16832 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12503491 0.94 FGFR4 (0.69) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1250780 0.92 FGFR4 (0.60) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1889240 0.91 FGFR4 (0.76) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL13613081 0.91 FGFR4 (0.63) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1891024 0.90 FGFR4 (0.64) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL12412085 0.90 FGFR4 (0.59) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL12673672 0.89 FGFR4 (0.58) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1894000 0.89 FGFR4 (0.62) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1895585 0.87 FGFR4 (0.49) FGFR4KDRFGFR1FLT1FLT4
SCHEMBL1897675 0.86 FGFR4 (0.58) FGFR4KDRFGFR1FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES FUNAHASHI YASUHIRO 2011-05-19 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 FGFR4 2049/4885KDR 2687/4885FGFR1 499/4885
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES GNG2, GCG, FRG1 FGFR4 2109/4885KDR 2782/4885FGFR1 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.